LGND Total Non-Current Liabilities
Ligand Pharmaceuticals Inc · Total Non-Current Liabilities

LGND Total Non-Current Liabilities
Latest reported$505.98Mperiod ending
LGND FY Total Non-Current Liabilities ($12.30M → $505.98M)
Annual total non-current liabilities
High-resolution chart · PNG
LGND total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 505,977,999 | |
| 74,223,000 | |
| 69,521,000 | |
| 66,373,000 | |
| 434,766,000 | |
| 552,649,000 | |
| 710,681,000 | |
| 617,640,000 | |
| 13,506,000 | |
| 3,603,000 | |
| 208,702,000 | |
| 210,842,000 | |
| 26,161,000 | |
| 42,336,000 | |
| 70,061,000 | |
| 46,920,000 | |
| 57,783,000 | |
| 111,199,000 | |
| 93,195,000 | |
| 127,891,000 | |
| 189,827,000 | |
| 191,071,000 | |
| 176,478,000 | |
| 166,059,000 | |
| 143,622,000 | |
| 140,132,000 | |
| 139,500,000 | |
| 140,500,000 | |
| 51,400,000 | |
| 53,800,000 | |
| 49,800,000 | |
| 12,300,000 |